Literature DB >> 15094999

All in the family: aldose reductase and closely related aldo-keto reductases.

J M Petrash1.   

Abstract

Aldose reductase catalyzes the first step in the polyol pathway and is thought to be involved in the pathogenesis of diabetic complications. In addition to polyol synthesis, aldose reductase may have multiple other activities that intersect with signal processing and oxidative defense mechanisms. Multiple aldose reductase-like proteins have been discovered to have structures and catalytic properties that broadly overlap those of aldose reductase. This chapter will summarize new insights into properties and functions of aldose reductase and closely related members of the aldo-keto reductase enzyme superfamily.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094999     DOI: 10.1007/s00018-003-3402-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  15 in total

1.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Authors:  T H Lee; E R Marcantonio; C M Mangione; E J Thomas; C A Polanczyk; E F Cook; D J Sugarbaker; M C Donaldson; R Poss; K K Ho; L E Ludwig; A Pedan; L Goldman
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).

Authors:  Kim A Eagle; Peter B Berger; Hugh Calkins; Bernard R Chaitman; Gordon A Ewy; Kirsten E Fleischmann; Lee A Fleisher; James B Froehlich; Richard J Gusberg; Jeffrey A Leppo; Thomas Ryan; Robert C Schlant; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Alice K Jacobs; Loren F Hiratzka; Richard O Russell; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

3.  Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?

Authors:  Don Poldermans; Jeroen J Bax; Olaf Schouten; Aleksandar N Neskovic; Bernard Paelinck; Guido Rocci; Laura van Dortmont; Anai E S Durazzo; Louis L M van de Ven; Marc R H M van Sambeek; Miklos D Kertai; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2006-08-17       Impact factor: 24.094

4.  Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery.

Authors:  Don Poldermans; Jeroen J Bax; Eric Boersma; Stefan De Hert; Erik Eeckhout; Gerry Fowkes; Bulent Gorenek; Michael G Hennerici; Bernard Iung; Malte Kelm; Keld Per Kjeldsen; Steen Dalby Kristensen; Jose Lopez-Sendon; Paolo Pelosi; François Philippe; Luc Pierard; Piotr Ponikowski; Jean-Paul Schmid; Olav F M Sellevold; Rosa Sicari; Greet Van den Berghe; Frank Vermassen
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

5.  Beta-blockers as first-line antihypertensive therapy the crumbling continues.

Authors:  Carl J Lavie; Franz H Messerli; Richard V Milani
Journal:  J Am Coll Cardiol       Date:  2009-09-22       Impact factor: 24.094

6.  [Perioperative cardiac care for non-cardiac surgery : 2009 Guidelines of the European Society of Cardiology].

Authors:  H-J Priebe
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

7.  Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery.

Authors:  Peter G Noordzij; Eric Boersma; Jeroen J Bax; Harm H H Feringa; Frodo Schreiner; Olaf Schouten; Miklos D Kertai; Jan Klein; Hero van Urk; Abdou Elhendy; Don Poldermans
Journal:  Am J Cardiol       Date:  2006-02-28       Impact factor: 2.778

Review 8.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

9.  Impact of heart failure on patients undergoing major noncardiac surgery.

Authors:  Bradley G Hammill; Lesley H Curtis; Elliott Bennett-Guerrero; Christopher M O'Connor; James G Jollis; Kevin A Schulman; Adrian F Hernandez
Journal:  Anesthesiology       Date:  2008-04       Impact factor: 7.892

10.  Activities of daily living and cardiovascular complications following elective, noncardiac surgery.

Authors:  R A Wiklund; H D Stein; S H Rosenbaum
Journal:  Yale J Biol Med       Date:  2001 Mar-Apr
View more
  58 in total

1.  Cloning and characterization of AKR4C14, a rice aldo-keto reductase, from Thai Jasmine rice.

Authors:  Rawint Narawongsanont; Suthamma Kabinpong; Budsakorn Auiyawong; Chonticha Tantitadapitak
Journal:  Protein J       Date:  2012-01       Impact factor: 2.371

Review 2.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

3.  Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals.

Authors:  Rui Wang; Guoqing Wang; Megan J Ricard; Barbara Ferris; Yael Strulovici-Barel; Jacqueline Salit; Neil R Hackett; Lorraine J Gudas; Ronald G Crystal
Journal:  Chest       Date:  2010-08-12       Impact factor: 9.410

4.  Identification and functional characterization of four novel aldo/keto reductases in Anabaena sp. PCC 7120 by integrating wet lab with in silico approaches.

Authors:  Chhavi Agrawal; Shivam Yadav; Shweta Rai; Antra Chatterjee; Sonia Sen; Ruchi Rai; L C Rai
Journal:  Funct Integr Genomics       Date:  2017-02-11       Impact factor: 3.410

5.  Estrogen-responsive nitroso-proteome in uterine artery endothelial cells: role of endothelial nitric oxide synthase and estrogen receptor-β.

Authors:  Hong-hai Zhang; Lin Feng; Wen Wang; Ronald R Magness; Dong-bao Chen
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

6.  Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells.

Authors:  Kun-Che Chang; Anson Snow; Daniel V LaBarbera; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2014-10-18       Impact factor: 5.192

7.  Biochemical and pharmacological characterization of AZD1981, an orally available selective DP2 antagonist in clinical development for asthma.

Authors:  J A Schmidt; F M Bell; E Akam; C Marshall; I A Dainty; A Heinemann; I G Dougall; R V Bonnert; C A Sargent
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.

Authors:  Zhenwang Tang; Chenglai Xia; Renbin Huang; Xiaoning Li; Wan-Chun Wang; Wangyuan Guo; Lili Duan; Weihao Luo; Deliang Cao; Di-Xian Luo
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

9.  Microbial gutta-percha degradation shares common steps with rubber degradation by Nocardia nova SH22a.

Authors:  Quan Luo; Sebastian Hiessl; Anja Poehlein; Alexander Steinbüchel
Journal:  Appl Environ Microbiol       Date:  2012-12-07       Impact factor: 4.792

10.  Upregulation of aldose reductase during foam cell formation as possible link among diabetes, hyperlipidemia, and atherosclerosis.

Authors:  Christian A Gleissner; John M Sanders; Jerry Nadler; Klaus Ley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.